Drug Discovery And Development
Expert's Opinion
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
RevolKa and La Jolla Institute Partner to Create Antigens for Next-Gen Vaccines
Aim to address unmet medical needs in infectious diseases.04.19.24
-
Breaking News | Drug Development | Trials & Filings
Genentech's Alecensa Approved in Early-Stage NSCLC
Phase III ALINA study demonstrates Alecensa reduced the risk of disease recurrence or death by 76%.04.19.24
-
Biologics, Proteins, Vaccines
Needle-Free Vaccines: Leading Innovation in Drug Delivery
Experts discuss alternative administration roots and why they matter.Online Exclusives Charles Sternberg, Associate Editor 04.18.24
-
Breaking News | Collaborations & Alliances | Drug Discovery
Aurigene & Vipergen Partner to Co-Market & Offer DEL Screening Technologies to Customers
Will also co-develop new DELs with an emphasis on novel chemical diversity and drug-likeness to further strengthen their service offering.04.18.24
-
Biologics, Proteins, Vaccines | Drug Development
Gene Therapy is Having its Moment: Can the Clinical Research Ecosystem Seize It?
Address risks without limiting innovation and ensure trial development process aligns with clinical needs and regulatory standards.James Riddle, Senior Vice President, Global Review Operations, Advarra 04.18.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
ExoXpert, Neucore Bio to Evaluate Advanced Exosome Loading
Aims to enable greater clarity on maximizing the therapeutic effect of Neucore’s FiXE platform as it advances clinical development.04.18.24
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec and Variant Bio Partner to Discover & Develop Treatments for Fibrosis
The partnership leverages Variant Bio’s genomic discovery capabilities and VB-Inference platform as well as Evotec’s expertise in antifibrotic drug discovery.04.18.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | QA/QC
Cellares Launches Cell Q Automated cGMP QC Workcell for Cell Therapies
Aims to resolve manual QC processing bottleneck and extend IDMO capabilities from manufacturing through quality control.04.18.24
-
Breaking News | Drug Development | Industry News | Information Technology
Tris Pharma Launches Digital Health Business
Through licensing agreement with Braingaze aims to develop and commercialize digital products for ADHD.04.17.24
-
Injectables | Laboratory Testing | Vials
Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing
This webinar will cover how headspace methods are developed and validated for a variety of product-container configurations including pre-filled syringes.04.17.24
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Drug Development
CordenPharma, GENEPEP Celebrate R&D Alliance
Leverages peptide drug substance discovery and clinical development expertise.04.17.24
-
Breaking News | Collaborations & Alliances | Drug Development
CureVac, MD Anderson Enter Strategic Cancer Vax Pact
Aims to develop differentiated cancer vaccine candidates in selected hematological and solid tumor indications.04.16.24
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
Charles River Launches Alternative Methods Advancement Project
Aims to develop alternatives to reduce animal testing and to drive a new standard for drug discovery and development.04.16.24
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Development | Formulation Development | Preclinical Outsourcing
Medincell, Abbvie Enter Development and Commercialization Pact
Medincell will provide formulation activities and preclinical studies, including supportive CMC work to advance candidates into trials.04.16.24
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Process Development
Kincell Bio to Acquire Imugene’s NC Mfg. Facility
Expands capacity to provide development and manufacturing support for the immunocellular therapy market.04.16.24
-
Breaking News | Drug Development
Viatris Welcomes Corinne Le Goff as Chief Commercial Officer
Le Goff is a biotechnology and pharmaceutical executive with more than 25 years of experience leading and building teams globally.04.15.24
-
Bio News | Breaking News | Drug Development
Applied Therapeutics Names New Chief Commercial Officer
Dale Hooks joins Applied with over 30 years of biopharmaceutical experience in rare disease marketing and sales.04.15.24
-
Drug Development | Trials & Filings
Genentech’s Columvi Meets Primary Endpoint in DLBCL
Phase III study demonstrated that people lived longer when treated with Columvi in combination with gemcitabine and oxaliplatin.04.15.24
-
Breaking News | cGMP Manufacture | Drug Development
KBI Biopharma Names JB Agnus as Chief Business Officer
Agnus brings more than two decades of experience across various sectors of the biopharmaceutical industry.04.15.24
-
Breaking News | Collaborations & Alliances | R&D
Modalis Joins the Ginkgo Technology Network
Grants Ginkgo’s customers access to Modalis’ proprietary epigenome modulation technology, CRISPR-GNDM.04.12.24
